Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

I said, do not trust me, take it to a professional. MANF is very interesting for a number of processes. It remains to be seen if it will make it to the clinic. There will be other targets ( as Fumi notes ) that people will go after. Along the way, the prs will do wonders for the stock.

As of right now, the Accuracy of Lympro is 78%, according to the company. That will not buy you a cup of coffee. The fact that cell cycle dysfunction is involved is of research interest but it will not amount to a lot of money.

Given the class of medication in which Eltoprazine sits, it is unlikely that people will tolerate this medication in a large study.

There are the take homes, after that there is a lot of information.